Kestra Medical Technologies, Ltd. (KMTS) Guidance & Earnings Results
On 2026-09-14 Kestra Medical Technologies, Ltd. raised guidance: "FY27 revenue raised to $141M from…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason
KMTSKestra Medical Technologies, Ltd.Follow KMTS — free
—
Price chart with a free account
- Market cap
- 1.7B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Dec, in 47 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 14 Sep 26 | Raised | FY27 revenue raised to $141M from $137M · full year |
| 14 Jul 26 | Raised | FY27 revenue guidance of $137M, representing 44% growth over FY26 · full year |
| 17 Mar 26 | Raised | FY26 revenue guidance raised to $93M from $91M (prior) and $85M (initial) · full year |
| 11 Dec 25 | Raised | FY26 revenue guidance raised to $91M from $88M (prior) and $85M (initial) · full year |
| 11 Sep 25 | Raised | FY26 revenue guidance raised from $85M to $88M · full year |
Kestra Medical Technologies, Ltd. — questions
- What guidance did Kestra Medical Technologies, Ltd. give?
- On 2026-09-14: "FY27 revenue raised to $141M from $137M"
- When does Kestra Medical Technologies, Ltd. report earnings?
- Kestra Medical Technologies, Ltd.'s next earnings report is expected on 2026-12-11.
Every figure on this page comes from Kestra Medical Technologies, Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.